Microsoft hikes dividend by 15 percent to 23 cents
(AP)—Microsoft Corp. says it is increasing its quarterly dividend by 15 percent.
Sep 18, 2012
1 / 5 (1)
0
Sep 18, 2012
1 / 5 (1)
0
Facebook sidelines contested Merck profile page
Facebook will sideline a Merck page at the social network until a pair of US and German companies work out which one gets the online address, a source familiar with the matter told AFP.
Nov 29, 2011
not rated yet
0
New way of synthesizing organic chemicals mimics nature
Organic chemists have found a new way of synthesizing multiple complex organic molecules that until now have needed to be synthesized using time-consuming methods. The new strategy, which mimics natural biosynthesis methods, ...
Jul 15, 2011
4.8 / 5 (5)
0
|
FDA links some prostate drugs to cancer risk
(AP) -- The Food and Drug Administration expanded the warning label on a group of prostate drugs Thursday, saying they may increase the risk of a more serious form of prostate cancer.
Jun 09, 2011
3 / 5 (1)
0
UNICEF discloses vaccine prices for 1st time
UNICEF is for the first time publicizing what drugmakers charge it for vaccines, as the world's biggest buyer of lifesaving immunizations aims to spark price competition in the face of rising costs.
May 29, 2011
5 / 5 (3)
1
FDA says Vertex hepatitis drug is highly effective
(AP) -- Federal health officials say a highly anticipated hepatitis C drug from Vertex Pharmaceuticals successfully treats a clear majority of patients in less time than older medicines that have been used for 20 years.
Apr 26, 2011
not rated yet
1
FDA says Merck drug successfully fights hepatitis
Federal health officials said Monday a highly-anticipated drug to treat hepatitis C made by Merck appears to cure more patients in less time than established drugs that have been used for 20 years. But the agency has questions ...
Apr 25, 2011
not rated yet
0
Merck pays J&J $500mn in drug row settlement
Merck said Friday it has agreed to pay fellow US pharmaceutical giant Johnson & Johnson $500 million to end a two-year tussle over profit-sharing deals for two anti-inflammatory drugs.
Apr 15, 2011
not rated yet
1
Merck says US rejects its MS drug
German pharmaceutical group Merck KgaA said Wednesday that the US Food and Drug Administration (FDA) has refused to approve use of its multiple sclerosis treatment Cladribine.
Mar 02, 2011
5 / 5 (1)
0
New hope for hepatitis C, an often hidden disease
There's new hope for an overlooked epidemic: Two powerful drugs are nearing the market that promise to help cure many more people of liver-attacking hepatitis C - even though most who have the simmering infection ...
Jan 17, 2011
4.3 / 5 (6)
3
Major international study to test new heart disease drug
(PhysOrg.com) -- A major international study to test whether a new type of cholesterol treatment can prevent coronary deaths and heart attacks will start in early 2011. The study will be coordinated by the ...
Nov 18, 2010
not rated yet
1
Vaccination reduces burden of childhood rotavirus disease
Vaccination of infants with Rotarix or RotaTeq significantly reduces the rate of severe rotavirus diarrhoea, hospitalizations, medical attention due to rotavirus and severe diarrhoea from all causes. The vaccines are not ...
May 11, 2010
not rated yet
0
Study raises new questions about Merck pill Zetia
(AP) -- A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.
Nov 16, 2009
5 / 5 (3)
1
FDA won't accept Merck's application for new drug
(AP) -- U.S. regulators have refused to accept drugmaker Merck & Co.'s application for a new, combination cholesterol pill that includes rival Pfizer's Lipitor, the world's top-selling drug.
Nov 02, 2009
3 / 5 (1)
0
Bristol-Myers gets EU approval for diabetes drug
(AP) -- Drugmaker Bristol-Myers Squibb Co. said Monday that its new diabetes drug, Onglyza, has been approved for sale in the European Union's 27 countries.
Oct 05, 2009
not rated yet
0
